Clinical Trials Browser

Phase 1 × INDUSTRY × Small Cell Lung Cancer Extensive Stage × Clear all

NCT05680922 2025-05-22

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer

Phase 1 Recruiting

EndocrineNETThoracic

Small Cell Lung Cancer Extensive Stage